Brief: China Shineway Pharmaceutical Group Says Xu Sheng Will No Longer Serve As CEO
02/07/2019 10:19
July 2 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK :
* XU SHENG WILL NO LONGER SERVE AS AN EXECUTIVE DIRECTOR AND
CHIEF
EXECUTIVE OFFICER
Source text for Eikon: ID:nHKS1rYvz6
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln